Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis
Harumoto Yamada, Koju Watanabe, Tsuyoshi Saito, Haruhisa Hayashi, Yoshiaki Niitani, Toshiyuki Kikuchi, Akira Ito, Kyosuke Fujikawa, L. Stefan Lohmander
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis'. Together they form a unique fingerprint.